Table 3.

Leukocyte parameters according to patient category.

Variable	CAD (non-MI) (n = 1079)	MI (n = 604)	Control (n = 1683)	p CAD versus control	p MI versus control	p CAD versus MI
WBC count, (109/l)	6.82 ± 1.86	8.69 ± 2.91	6.25 ± 1.54	<0.001	<0.001	<0.001
Neutrophil count, (109/l)	4.05 ± 1.46	5.83 ± 2.73	3.52 ± 1.17	<0.001	<0.001	<0.001
Neutrophil percentage, (%)	58.61 ± 8.91	64.97 ± 10.98	55.78 ± 7.77	<0.001	<0.001	<0.001
Monocyte count, (109/l)	0.48 ± 0.17	0.64 ± 0.30	0.40 ± 0.13	<0.001	<0.001	<0.001
Monocyte percentage, (%)	7.11 ± 1.89	7.52 ± 1.41	6.46 ± 1.60	<0.001	<0.001	<0.001
Basophil count, (109/l)	0.029 ± 0.020	0.027 ± 0.020	0.033 ± 0.018	<0.001	<0.001	0.060
Basophil percentage, (%)	0.54 ± 0.28	0.33 ± 0.24	0.54 ± 0.28	<0.001	<0.001	<0.001
Eosinophil count, (109/l)	0.14 ± 0.12	0.13 ± 0.24	0.15 ± 0.12	0.338	<0.001	<0.001
Eosinophil percentage, (%)	2.21 ± 1.71	1.71 ± 2.44	2.41 ± 1.75	0.003	<0.001	<0.001
Lymphocyte count, (109/l)	2.11 ± 0.66	2.07 ± 0.77	2.14 ± 0.58	0.082	0.003	0.482
Lymphocyte percentage, (%)	31.65 ± 7.93	25.48 ± 9.43	34.82 ± 7.28	<0.001	<0.001	<0.001

CAD, coronary artery disease; MI, myocardial infarction; WBC, white blood cell.

Continuous variables are expressed as the mean ± SD. P values of the continuous variables were calculated using one-way ANOVA.